91 related articles for article (PubMed ID: 20414024)
21. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
[TBL] [Abstract][Full Text] [Related]
22. [Optimal volume of medicinal solution in the portable disposable infusion pump (SUREFUSER A) for FOLFOX6, FOLFIRI therapy of colorectal cancer patients (2nd report)-influence of temperature on outflow speed of the medicinal solution].
Kawabata Y; Nakagawa A
Yakugaku Zasshi; 2010 Apr; 130(4):621-7. PubMed ID: 20372010
[TBL] [Abstract][Full Text] [Related]
23. [The optimal volume of medicinal solution in the portable disposable infusion pump (SUREFUSER A) for FOLFOX6, FOLFIRI therapy of colorectal cancer patients].
Kawabata Y; Nakagawa A; Uchikoshi H; Tamiya Y
Yakugaku Zasshi; 2009 Mar; 129(3):359-64. PubMed ID: 19252394
[TBL] [Abstract][Full Text] [Related]
24. Spontaneous or imposed circadian changes in plasma concentrations of 5-fluorouracil coadministered with folinic acid and oxaliplatin: relationship with mucosal toxicity in patients with cancer.
Metzger G; Massari C; Etienne MC; Comisso M; Brienza S; Touitou Y; Milano G; Bastian G; Misset JL; Lévi F
Clin Pharmacol Ther; 1994 Aug; 56(2):190-201. PubMed ID: 8062496
[TBL] [Abstract][Full Text] [Related]
25. Reversible leukoencephalopathy with stroke-like presentation in a patient with 5-dihydropyrimidine dehydrogenase deficiency treated with continuous 5-fluorouracil infusion.
Li J; Lee JJ; Chu E; Baehring JM
Clin Colorectal Cancer; 2012 Sep; 11(3):215-7. PubMed ID: 22410472
[No Abstract] [Full Text] [Related]
26. [Establishment of a Needle-Removal Method Considering Anticancer Drug Exposure after Continuous Administration of Fluorouracil Using an Infusion Pump].
Furihata S; Yatsu N; Ohno R; Takamatsu N; Anami S
Gan To Kagaku Ryoho; 2021 Jul; 48(7):939-943. PubMed ID: 34267032
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic metastasis from colon carcinoma treated with radiotherapy with palliative benefit.
Saif MW; Kaley K
JOP; 2010 Nov; 11(6):644-5; author reply 650. PubMed ID: 21068505
[No Abstract] [Full Text] [Related]
28. [Present status of home therapy cancer patients using an infusor].
Tsuji Y; Tsushima T; Tanaka S; Mizushima T; Tamura F; Chiba H; Honda K; Makino K; Ohura K; Sumiyoshi T; Yoshizaki N; Kondo H
Gan To Kagaku Ryoho; 2006 Dec; 33 Suppl 2():260-3. PubMed ID: 17469354
[TBL] [Abstract][Full Text] [Related]
29. Hypersensitivity reaction caused by folinic acid administration: a case report and literature review.
Florit-Sureda M; Conde-Estévez D; Vidal J; Montagut C
J Chemother; 2016 Dec; 28(6):500-505. PubMed ID: 26042586
[TBL] [Abstract][Full Text] [Related]
30. Dual deficiency of DPD and UGT1A1 in a case of colon cancer.
Rawlley B; Diab O; Al-Rajabi R; Carroll E; Melancon T; Kasi A
Pharmacogenomics; 2020 Dec; 21(18):1265-1269. PubMed ID: 33203301
[No Abstract] [Full Text] [Related]
31. Pharmacoeconomic aspects of FOLFIRI or FOLFOX regimens administered with a fully ambulatory pump compared to the day hospital setting.
Tampellini M
Tumori; 2010; 96(3):438-42. PubMed ID: 20845805
[TBL] [Abstract][Full Text] [Related]
32. An alternative method to overcome central venous portable external infusion pump blockage in patients receiving weekly 24-hour high-dose fluorouracil and leucovorin.
Yeh KH; Cheng AL
J Clin Oncol; 1994 Apr; 12(4):875-6. PubMed ID: 8151330
[No Abstract] [Full Text] [Related]
33. Irinotecan chemotherapy associated with transient dysarthria and aphasia.
De Marco S; Squilloni E; Vigna L; Bertagnolio MF; Sternberg CN
Ann Oncol; 2004 Jul; 15(7):1147-8. PubMed ID: 15205214
[No Abstract] [Full Text] [Related]
34. Acceptance of external infusion pumps in patients with advanced breast cancer receiving continuous infusion fluorouracil.
Lombardi D; Di Lauro V; Piani B; Scuderi C; Spazzapan S; Magri MD; Crivellari D; Annunziata MA; De Cicco M; Veronesi A
Tumori; 2003; 89(5):488-91. PubMed ID: 14870769
[TBL] [Abstract][Full Text] [Related]
35. Neutrophilic eccrine hidradenitis in a patient with FOLFOX chemotherapy.
da Silva Sousa AC; Guedes Pereira RVA; Menezes NMBVN; Furtado AMC; Baptista AM
Acta Dermatovenerol Alp Pannonica Adriat; 2018 Dec; 27(4):207-209. PubMed ID: 30564834
[TBL] [Abstract][Full Text] [Related]
36. Nonspecific but significant.
Chen YG; Kao WY; Tsai SH
Am J Med; 2012 May; 125(5):461-4. PubMed ID: 22482844
[No Abstract] [Full Text] [Related]
37. Takotsubo cardiomyopathy and Fluorouracil: case report and review of the literature.
Grunwald MR; Howie L; Diaz LA
J Clin Oncol; 2012 Jan; 30(2):e11-4. PubMed ID: 22147738
[No Abstract] [Full Text] [Related]
38. Advances in colon cancer.
Levin M
Drug News Perspect; 2003 Jun; 16(5):325-9. PubMed ID: 12942164
[TBL] [Abstract][Full Text] [Related]
39. Stability of commercial solutions of 5-fluorouracil for continuous infusion in an ambulatory pump.
Fournet A; Gilard V; Malet-Martino M; Martino R; Canal P; De Forni M
Cancer Chemother Pharmacol; 2000; 46(6):501-6. PubMed ID: 11138464
[TBL] [Abstract][Full Text] [Related]
40. Continuous infusion of chemotherapy on an outpatient basis via a totally implanted venous access port.
Nanninga AG; de Vries EG; Willemse PH; Oosterhuis BE; Sleijfer DT; Hoekstra HJ; Mulder NH
Eur J Cancer; 1991; 27(2):147-9. PubMed ID: 1827278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
